F1RST Up offers an exclusive alliance of 200 physician investigators, in nephrology, and accelerates study startup by eliminating the administrative and contracting burdens.
Frenova Renal Research has launched F1RST Up (Frenova Rapid STart Up), an exclusive alliance with clinical research sites selected from Frenova’s investigative site network of more than 200 physician investigators, which accelerates study startup by eliminating the administrative and contracting burdens. The investigators provide care to approximately 600,000 kidney disease patients, who have cardio-renal conditions, chronic kidney disease (CKD), end stage renal disease (ESRD), cardiovascular disease, rare diseases, and infectious diseases and transplant.
Read the
